Russian COVID-19 vaccine to arrive in India this week for Phase II/III human trials.
Mumbai witnessed a decline in the number of new cases on Monday, even as all religious places across Maharashtra opened their gates to devotees. Mumbai exhibited positive trends yesterday, with 409 fresh coronavirus infections along with increased 891 recoveries and negative active stats, clocking at 499 cases. Presently, Mumbai total COVID-19 tally stands at 2,70,119 cases, about which 13,033 are active ones. The city's recuperation rate stands at 90.9% with 2,45,734 recoveries.
COVID-19 vaccines start trials in India
In yet another attempt to develop a vaccine against SARS Cov-2, to defeat the global pandemic, Russia's Sputnik V vaccine for COVID-19 will arrive at Kanpur's Ganesh Shankar Vidyarthi Medical College this week for Phase II/III human clinical trials. The approval to conduct these trials was sanctioned after a Hyderabad based laboratory received approval from the Drugs Controller General of India (DCGI).
On Monday, vaccine maker Bharat Biotech also announced that it has initiated the Phase II trials for Covaxin, India's first indigenous vaccine for COVID-19. This phase will test a batch of 26,000 volunteers across the nation with the partnership of Indian Council of Medical Research ICMR.